NASDAQ · ELAB
PMGC Holdings Inc.
Healthcare · Biotechnology
$2.60
Down-$0.04 (-1.52%)
Updated Nov 2, 2026, 1:59 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.71M
- P/E ratio
- -0.52
- Dividend yield
- 0.00%
- 52-week range
- $0.84 – $147.12
- Volume
- 7.49K
- Avg. volume
- 556.88K
Price performance · ELAB
ELAB price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
ELAB closed at $2.60 after 20 trading sessions, down 20.49% for the selected period.
- Last close
- $2.60
- Period change
- -20.49%
- Period low
- $2.57
- Period high
- $3.27
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $2.64 | $2.70 | $2.51 | $2.60 | 7.49K |
| Oct 29, 2026 | $2.57 | $2.70 | $2.52 | $2.64 | 6.7K |
| Oct 28, 2026 | $2.745 | $2.7793 | $2.56 | $2.57 | 7.37K |
| Oct 27, 2026 | $2.79 | $2.86 | $2.5195 | $2.58 | 9.11K |
| Oct 26, 2026 | $2.71 | $2.755 | $2.585 | $2.61 | 17.17K |
| Oct 23, 2026 | $2.76 | $2.76 | $2.7057 | $2.7057 | 1.37K |
| Oct 22, 2026 | $2.695 | $2.765 | $2.62 | $2.66 | 5.18K |
| Oct 21, 2026 | $2.7992 | $2.81 | $2.758 | $2.78 | 3.44K |
| Oct 20, 2026 | $2.87 | $2.87 | $2.75 | $2.81 | 4.8K |
| Oct 19, 2026 | $2.81 | $2.89 | $2.80 | $2.83 | 4.85K |
| Oct 16, 2026 | $3.00 | $3.0299 | $2.6833 | $2.77 | 12.55K |
| Oct 15, 2026 | $2.94 | $3.06 | $2.785 | $3.04 | 15.83K |
| Oct 14, 2026 | $3.01 | $3.07 | $2.96 | $2.97 | 11.19K |
| Oct 13, 2026 | $3.05 | $3.06 | $2.85 | $2.96 | 13.69K |
| Oct 12, 2026 | $3.06 | $3.14 | $3.00 | $3.05 | 8.64K |
| Oct 9, 2026 | $3.12 | $3.12 | $3.07 | $3.08 | 4.05K |
| Oct 8, 2026 | $3.24 | $3.3351 | $3.06 | $3.125 | 16.56K |
| Oct 7, 2026 | $3.19 | $3.39 | $3.12 | $3.14 | 19.94K |
| Oct 6, 2026 | $3.23 | $3.30 | $3.08 | $3.27 | 14.66K |
| Oct 5, 2026 | $3.30 | $3.36 | $3.0601 | $3.27 | 41.54K |
Latest ELAB news
The latest Smart Investors Daily articles mentioning ELAB.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

